‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.PSA to transform accreditation amid shake-up
With the AACP closing its doors at the end of the year, PSA is stepping up to become the new home of accreditation.
Are you up to speed on COVID-19 antiviral eligibility changes?
On 11 July, millions of Australians gained access to oral COVID-19 antiviral treatments after the eligibility criteria widened significantly.
EC options underutilised by pharmacists
Community pharmacists could more frequently give patients a choice between the two emergency contraception drugs available in Australia.
The mystery shopper exercise conducted by University...
N-acetylcysteine for methamphetamine dependence
NAC has the potential to be a much-needed and affordable pharmacological option for harm minimisation related to not only methamphetamine dependence, but also of...
Bridget Totterman is making her own path
Meet Bridget Totterman, PSA's 2020 Queensland Pharmacist of the Year.
Dexamethasone and COVID-19
A cheap and widely used corticosteroid may be employed by Australian doctors in the treatment of seriously ill COVID-19 patients.
